跳至主要内容
临床试验/ACTRN12617000598381
ACTRN12617000598381进行中(未招募)未知

A pilot study to evaluate the effectiveness of daily 0.01% atropine eye drop therapy in modifying the progression of myopia, in Australian Children.

ions Eye Institute0 个研究点目标入组 153 人开始时间: 2017年4月27日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
153

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
6 Years 至 16 Years(—)
性别
All

入选标准

  • Aged 6-16 years
  • Myopia with spherical equivalent refractive error greater or equal to -1.5D in each eye
  • Documented myopic progression of greater or equal to -0.5D over the previous 12 months in either eye
  • Astigmatism less than -1.5D
  • An intraocular difference in spherical equivalent < 1D
  • Corrected visual acuity greater than logMar 0.2
  • Normal ocular health
  • No history of cardiac/respiratory disease
  • Willing and able to provide details of parents country of origin
  • Able to provide appropriate parental/carer consent

排除标准

  • Children who are currently wearing or have worn orthokeratology lenses over the previous two years for myopia control.

研究者

发起方
ions Eye Institute

相似试验